These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10105708)

  • 21. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
    Besarab A; Bolton WK; Browne JK; Egrie JC; Nissenson AR; Okamoto DM; Schwab SJ; Goodkin DA
    N Engl J Med; 1998 Aug; 339(9):584-90. PubMed ID: 9718377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacy-managed patient-controlled analgesia service.
    McCall LJ; Dierks DR
    Am J Hosp Pharm; 1990 Dec; 47(12):2706-10. PubMed ID: 2278287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality assurance program for a hospital investigational-drug service.
    Tankanow RM; Savitsky ME; Volger BW; Ryan ML; Colvin CL
    Am J Hosp Pharm; 1989 May; 46(5):962-9. PubMed ID: 2729303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observation on patients' evaluations and nurses' involvements.
    Ogawa K; Ishige K; Sugo M; Kamagata R
    Jpn Hosp; 1989 Jul; 8():57-61. PubMed ID: 10294020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of developing a QA program. Part I.
    Schardin KE; Parra SA
    Nephrol News Issues; 1990 Jun; 4(6):12-3. PubMed ID: 2402305
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia.
    Baldamus C; Krivoshiev S; Wolf-Pflugmann M; Siebert-Weigel M; Koytchev R; Bronn A
    Adv Ther; 2008 Nov; 25(11):1215-28. PubMed ID: 18931828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an automated bedside dispensing machine on medication errors.
    Barker KN; Pearson RE; Hepler CD; Smith WE; Pappas CA
    Am J Hosp Pharm; 1984 Jul; 41(7):1352-8. PubMed ID: 6465150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved survival with higher hematocrits: where is the evidence?
    Cotter DJ; Stefanik K; Zhang Y; Thamer M
    Semin Dial; 2004; 17(3):181-3. PubMed ID: 15144538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Documentation of pharmacist interventions in a decentralized unit dose system.
    Hoolihan RJ; Skoogman LH
    Hosp Pharm; 1991 Oct; 26(10):875-9. PubMed ID: 10114008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A; Spasovski G; Zafirov D; Polenakovic M
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a pharmaceutical care system in a neonatal intensive care satellite pharmacy.
    Johnson CJ; Lobas NH; Ivey MF
    Am J Hosp Pharm; 1993 Jun; 50(6):1158-63. PubMed ID: 8517454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of a computerized system at the pharmacy department of the University of Tokyo Hospital--impact of prescription order entry and computerized dispensing system.
    Tsubaki T; Orii T; Sugiura M
    Jpn Hosp; 1990 Jul; 9():61-7. PubMed ID: 10108044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators project.
    Bailie GR; Frankenfield DL; Prowant BF; McClellan W; Rocco MV
    Am J Kidney Dis; 1999 Jun; 33(6):1187-9. PubMed ID: 10352214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive pharmaceutical services in a small community hospital.
    Chase PA
    Am J Hosp Pharm; 1984 Jul; 41(7):1338-42. PubMed ID: 6465147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consultant evaluation of a hospital medication system: synthesis of a new system.
    Barker KN; Harris JA; Webster DB; Stringer JF; Pearson RE; Mikeal RL; Glotzhober GR; Miller GJ
    Am J Hosp Pharm; 1984 Oct; 41(10):2016-21. PubMed ID: 6496489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of epoetin alfa therapy for anemia of end-stage renal disease.
    Moran LJ; Carey P; Johnson CA
    Am J Hosp Pharm; 1992 Jun; 49(6):1451-4. PubMed ID: 1529988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and analysis of a non-floor stock controlled substance unit dose system in a pediatric hospital.
    Enderlin GM; Summerfield MR
    Hosp Pharm; 1992 Jan; 27(1):9-13. PubMed ID: 10116120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of clinical pharmacist interventions in a hemodialysis unit.
    Tang I; Vrahnos D; Hatoum H; Lau A
    Clin Ther; 1993; 15(2):459-64; discussion 432. PubMed ID: 8519051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.